Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00495950 · ClinicalTrials.gov registry record
Prospective Measurement of Post-Treatment Lymphedema
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 350
- Enrollment target
NCT00495950: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00495950 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 350 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00495950 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 350 participants
- Enrollment target
Study Summary
The goal of this study is to measure the amount of limb swelling (lymphedema) that sometimes occurs after melanoma treatment, and to find out how people feel and react to the diagnosis and treatment of melanoma.
Interventions
- BEHAVIORAL Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2006-05 |
| Est. Completion | 2016-11 |
What the finished NCT00495950 record still lists
NCT00495950 is an observational study that tracks outcomes without assigning an intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Questionnaire is the first listed.
NCT00495950 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00495950 about?
NCT00495950 is a clinical study titled "Prospective Measurement of Post-Treatment Lymphedema". The goal of this study is to measure the amount of limb swelling (lymphedema) that sometimes occurs after melanoma treatment, and to find out how people feel and react to the diagnosis and treatment of melanoma.
What is the current status of trial NCT00495950?
This trial is currently completed. The enrollment target is 350 participants. The study started on 2006-05. Estimated completion is 2016-11.
What interventions are being tested in trial NCT00495950?
The interventions under investigation include: Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT00495950?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia